| Literature DB >> 33728269 |
Nasser Ebrahimpour1,2, Mahdiyeh Khazaneha3,4, Mehrzad Mehrbani5, Parviz Rayegan5, Mahboobeh Raeiszadeh5.
Abstract
BACKGROUND AND AIM: An Aphrodisiac includes any drug and food that arouses sexual instinct, induces venereal desire, and increases pleasure and performance. The present study was designed to clinically evaluate efficacy and safety of Herbal Based Syrup (HBS) composed of Tribulus terrestris L., Panax ginseng C.A. Meyer., Zingiber officinale Rosc, Ceratonia siliqua L., Papaver rhoeas L., and Palm tree pollen on sexual experience of men. EXPERIMENTAL PROCEDURE: The study was designed as a double-blind randomized clinical trial. The main outcome measures were the responses obtained from using the Arizona Sexual Experience Scale (ASEX). The ASEX was completed by 100 married and seemingly healthy men before and after taking one dose of HBS or placebo and at least one sexual intercourse. In addition, possible side effects were observed. A split-plot ANOVA (SPANOVA) design was used for statistical analysis.Entities:
Keywords: Aphrodisiac; Libido; Natural product; Sexual desire; Traditional Persian medicine
Year: 2020 PMID: 33728269 PMCID: PMC7936107 DOI: 10.1016/j.jtcme.2020.01.004
Source DB: PubMed Journal: J Tradit Complement Med ISSN: 2225-4110
Characteristics of ingredients of HBS.
| Scientific name | Common name | Persian name | Family name | Used part | Type of extraction |
|---|---|---|---|---|---|
| Carob | Kharnoob | Fabaceae | Seed | Water maceration | |
| Honey | Honey | Asal | – | – | – |
| Ginseng | Ginseng | Araliaceae | Rhizome | Water maceration | |
| Common poppy | Shaghayegh | Papaveraceae | Flower | Water maceration | |
| Date palm | Tamr | Arecaceae | Flower | Water maceration | |
| Caltrop | Hasak | Zygophyllaceae | Aerial part | Distillate | |
| Ginger | Zanjafer | Zingiberaceae | Rhizome | Water maceration |
Physical characteristics of ingredients in HBS.
| Plants name | The amount used (%) | Total ash (%) | Humidity content (%) |
|---|---|---|---|
| Caltrop | 20 | 5.8 ± 1.3 | 3.5 ± 0.8 |
| Ginseng | 20 | 2.7 ± 0.4 | 7.14 ± 1.1 |
| Ginger | 20 | 4.9 ± 0.6 | 5.41 ± 0.6 |
| Carob | 10 | 4.0 ± 0.4 | 5.2 ± 0.7 |
| Common poppy | 10 | 4.6 ± 0.5 | 5.6 ± 0.6 |
| Date palm | 5 | 6.4 ± 1.0 | 3.2 ± 0.5 |
| Honey | 15 | – | – |
Effect of storage on changes in size and total phenolic content of HBS at different time intervals after preparation.
| Storage condition | Total phenolic content (mg GAE±SD) | Particle size (μm±SD) | ||||
|---|---|---|---|---|---|---|
| 24 h | 1month | 3months | 24 h | 1month | 3months | |
| 25 °C, 30%RH | 133.29 ± 2.02 | 131.40 ± 2.91 | 123.54 ± 3.10 | 67.05 ± 2.23 | 62.51 ± 5.32 | 59.70 ± 6.63 |
| 40 °C, 70%RH | – | 130.12 ± 1.67 | 119.32 ± 2.05 | – | 58.12 ± 3.44 | 41.66 ± 7.32 |
μm: micrometer, GAE: gallic acid equivalent, SD: standard deviation, RH: relative humidity.
Fig. 1The flow diagram of progress in parallel-randomized trial according to the CONSORT Guidelines.
Socio-demographic characteristics of the participants.
| Characteristic | Placebo(%)(N = 43) | HBS(%)(N = 46) | P value | ||
|---|---|---|---|---|---|
| Age | 20–29 | 5(11.6) | 3(6.5) | 0.293 | |
| 30–39 | 18(41.9) | 15(32.6) | |||
| 40–49 | 9(20.9) | 18(39.1) | |||
| 50–60 | 11(25.6) | 10(21.7) | |||
| Education | Under diploma | 8(18.6) | 6(13) | 0.703 | |
| Diploma | 20(46.5) | 19(41.3) | |||
| Post-diploma | 9(20.9) | 11(23.9) | |||
| License & up | 6(14) | 10(21.7) | |||
Comparison of scores obtained for each variable in the ASEX in two study groups before and after consumption of HBS with at least one sexual intercourse.
| Index | Pre-test | Post-test | Mean Square | df | F | P value | ||
|---|---|---|---|---|---|---|---|---|
| Placebo | HBS | Placebo | HBS | |||||
| Desire | 3.46 ± 1.27 | 3.25 ± 1.25 | 3.39 ± 1.21 | 1.56 ± 0.58 | 29.731 | 1.00 | 21.234 | 0.000 |
| Arousal | 3.32 ± 1.32 | 3.13 ± 1.30 | 3.36 ± 1.23 | 1.60 ± 0.74 | 17.085 | 1.00 | 9.644 | 0.003 |
| Erection | 3.02 ± 1.07 | 2.90 ± 0.94 | 3.30 ± 1.20 | 1.73 ± 0.80 | 12.513 | 1.00 | 12.035 | 0.001 |
| Orgasm | 3.30 ± 0.98 | 3.11 ± 1.09 | 3.15 ± 1.03 | 1.84 ± 0.86 | 23.946 | 1.00 | 18.143 | 0.000 |
| Satisfaction | 3.41 ± 1.11 | 3.20 ± 1.03 | 3.15 ± 1.03 | 1.80 ± 0.95 | 8.874 | 1.00 | 5.854 | 0.018 |
Pre-test: Results obtained before consuming of HBS and placebo, Post-test: Results obtained after consuming HBS and placebo, ASEX: Arizona Sexual Experience Scale Questionnaire.
Comparison of scores obtained for each variable in the ASEX in two study groups based on age before and after consumption of HBS with at least one sexual intercourse.
| Index | Age | Pre-test (Mean ± SD) | Post-test (Mean ± SD) | |||||
|---|---|---|---|---|---|---|---|---|
| Placebo | HBS | Placebo | HBS | |||||
| Desire | 20–30 | 3.40 ± 1.14 | 2.67 ± 1.15 | 3.00 ± 0.71 | 1.33 ± 0.58 | <0.001 | <0.001 | <0.001 |
| 30–40 | 2.83 ± 0.71 | 2.73 ± 0.80 | 2.56 ± 0.62 | 1.33 ± 0.62 | ||||
| 40–50 | 3.22 ± 1.72 | 3.17 ± 0.92 | 3.22 ± 1.56 | 1.61 ± 0.50 | ||||
| 50–60 | 4.73 ± 0.79 | 5.00 ± 0.82 | 4.55 ± 1.04 | 1.90 ± 0.57 | ||||
| Arousal | 20–30 | 3.20 ± 1.78 | 1.33 ± 0.57 | 2.40 ± 1.51 | 2.00 + 1.00 | <0.001 | 0.001 | <0.001 |
| 30–40 | 3.22 ± 1.26 | 2.86 ± 0.99 | 3.16 ± 1.29 | 1.33 ± 0.81 | ||||
| 40–50 | 2.44 ± 1.01 | 3.38 ± 0.91 | 2.44 ± 1.01 | 1.44 ± 0.51 | ||||
| 50–60 | 4.27 ± 0.90 | 4.70 ± 0.82 | 4.00 ± 1.00 | 2.20 ± 0.63 | ||||
| Erection | 20–30 | 2.40 ± 0.89 | 1.33 ± 0.57 | 3.00 ± 0.70 | 1.00 | <0.001 | 0.001 | 0.862 |
| 30–40 | 2.61 ± 0.77 | 2.93 ± 1.16 | 2.61 ± 0.77 | 1.46 ± 0.63 | ||||
| 40–50 | 2.66 ± 1.00 | 3.33 ± 1.02 | 2.33 ± 0.86 | 1.61 ± 0.50 | ||||
| 50–60 | 4.27 ± 0.64 | 4.40 ± 0.51 | 3.81 ± 0.75 | 2.60 ± 0.96 | ||||
| Orgasm | 20–30 | 3.20 ± 1.43 | 1.33 ± 0.57 | 3.20 ± 1.48 | 1.00 | <0.001 | 0.006 | 0.019 |
| 30–40 | 3.38 ± 0.97 | 2.93 ± 0.96 | 3.33 ± 1.08 | 1.66 ± 0.48 | ||||
| 40–50 | 2.66 ± 0.86 | 3.33 ± 0.97 | 2.33 ± 1.00 | 1.44 ± 0.51 | ||||
| 50–60 | 3.90 ± 0.70 | 3.80 ± 0.63 | 3.54 ± 0.93 | 3.10 ± 0.73 | ||||
| Satisfaction | 20–30 | 2.60 ± 0.89 | 2.33 ± 1.52 | 2.50 ± 1.06 | 2.00 ± 1.73 | <0.001 | 0.009 | 0.006 |
| 30–40 | 2.83 ± 1.09 | 2.80 ± 1.08 | 2.81 ± 1.07 | 1.53 ± 0.83 | ||||
| 40–50 | 2.77 ± 1.20 | 3.33 ± 0.97 | 3.14 ± 1.06 | 1.38 ± 0.50 | ||||
| 50–60 | 3.63 ± 0.50 | 3.30 ± 0.67 | 3.47 ± 0.60 | 2.60 ± 0.88 | ||||
P*: Before and after intervention (Tests of Within-Subjects Effects).
P**: Tests of Between -Group Effects and Within-Subjects Effects (combined test of inter- and intra-group effects).
P***: Time * group * age.